Primecap Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.49M | Sell |
1,986,687
-18,429
| -0.9% | -$69.5K | 0.01% | 273 |
|
|
2025
Q1 | $9.08M | Buy |
2,005,116
+72,499
| +4% | +$328K | 0.01% | 259 |
|
|
2024
Q4 | $13.7M | Sell |
1,932,617
-471,845
| -20% | -$3.34M | 0.01% | 245 |
|
|
2024
Q3 | $19.6M | Buy |
2,404,462
+25,000
| +1% | +$204K | 0.01% | 233 |
|
|
2024
Q2 | $15.2M | Buy |
2,379,462
+305,079
| +15% | +$1.95M | 0.01% | 239 |
|
|
2024
Q1 | $15.6M | Buy |
2,074,383
+654,806
| +46% | +$4.93M | 0.01% | 241 |
|
|
2023
Q4 | $13.1M | Buy |
1,419,577
+299,139
| +27% | +$2.77M | 0.01% | 250 |
|
|
2023
Q3 | $11.3M | Buy |
1,120,438
+519,004
| +86% | +$5.25M | 0.01% | 251 |
|
|
2023
Q2 | $7.52M | Buy |
601,434
+11,100
| +2% | +$139K | 0.01% | 268 |
|
|
2023
Q1 | $6.89M | Buy |
590,334
+119,000
| +25% | +$1.39M | 0.01% | 270 |
|
|
2022
Q4 | $5.01M | Sell |
471,334
-910
| -0.2% | -$9.67K | ﹤0.01% | 275 |
|
|
2022
Q3 | $4.58M | Buy |
472,244
+166,000
| +54% | +$1.61M | ﹤0.01% | 277 |
|
|
2022
Q2 | $4.44M | Buy |
306,244
+34,717
| +13% | +$503K | ﹤0.01% | 288 |
|
|
2022
Q1 | $7.1M | Buy |
271,527
+31,283
| +13% | +$817K | 0.01% | 276 |
|
|
2021
Q4 | $9.52M | Buy |
240,244
+7,335
| +3% | +$291K | 0.01% | 266 |
|
|
2021
Q3 | $11.6M | Sell |
232,909
-106
| -0% | -$5.3K | 0.01% | 261 |
|
|
2021
Q2 | $12.9M | Buy |
233,015
+11,000
| +5% | +$611K | 0.01% | 254 |
|
|
2021
Q1 | $10.4M | Buy |
222,015
+121,106
| +120% | +$5.66M | 0.01% | 263 |
|
|
2020
Q4 | $4.39M | Buy |
100,909
+36,000
| +55% | +$1.57M | ﹤0.01% | 279 |
|
|
2020
Q3 | $2.38M | Buy |
64,909
+20,000
| +45% | +$732K | ﹤0.01% | 279 |
|
|
2020
Q2 | $1.31M | Buy |
+44,909
| New | +$1.31M | ﹤0.01% | 287 |
|